Bordet Scientific Publications

Bordet Scientific Publications

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

Magaton IM, Blondeaux E, Hamy AS, Linn S, Bernstein-Molho R, Peccatori FA, Ferrari A, Carrasco E, Paluch-Shimon S, Agostinetto E, Venturelli M, Luis IMV, Rodriguez-Wallberg KA, Kim HJ, Sorouri K, Renaud T, Moore HCF, Cui W, Bajpa J, Rousset-Jablonski C, De Marchis L, Yerushalmi R, Wong SM, Han S, Phillips KA, Pogoda K, Puglisi F, Chirco A, Duhoux FP, Meattini I, Villarreal-Garza C, Vernieri C, Bruzzone M, Demeestere I, Azim HA, Partridge AH, Lambertini M

Assisted reproductive technology in young BRCA carriers with a pregnancy after breast cancer: An international cohort study.

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Paquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Paquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Paquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Paquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Paquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Paquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Paquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.

Paquier Z, Dhont J, Guiot T, Levillain H, Critchi G, Saude Conde R, Sclafani F, Flamen P, Reynaert N, Woff E, Hendlisz A

Development and Validation of an <sup>18</sup>F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Imaging Score to Predict 12-Week Life Expectancy in Advanced Chemorefractory Colorectal Cancer.
Erasme hospital

Erasmus Hospital

View all of Erasmus's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications